Coronary artery flow ten weeks after myocardial infarction or unstable angina: Effects of combined warfarin and aspirin therapy

International Journal of Cardiology

Volumn 69, Issue 1, 1999, Pages 19-25

  Williams, Michael J A ^a   Stewart, Ralph A H ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Acute coronary syndromes; Aspirin; Blood flow; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; ANTICOAGULANTS; ASPIRIN; BLOOD FLOW VELOCITY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; PLACEBOS; WARFARIN;

EID: 0033617351     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(98)00378-7     Document Type: Article

References (25)

1. Ohman E.M., Califf R.M., Topol E.J.et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation. 82:1990;781-791.
2. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-1622.
3. Simes R.J., Topol E.J., Holmes D.R. Jr.et al. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. Circulation. 91:1995;1923-1928.
4. Cohen M., Adams P.C., Parry G.et al. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users: primary end points analysis from the ATACS trial. Circulation. 89:1994;81-88.
5. Anand S.S., Flather M.D., Pogue J.M., Yusuf S. Long-term anticoagulation in patients with unstable angina: the Oasis pilot trial (abstract). Circulation. 96(suppl I):1997;I-40.
6. Williams M.J.A., Morison I.M., Parker J.H., Stewart R.A.H. Progression of the culprit lesion in unstable coronary artery disease with warfarin and aspirin versus aspirin alone - preliminary study. J Am Coll Cardiol. 30:1997;364-369.
7. Gibson C.M., Sandor T., Stone P.H., Pasternak R.C., Rosner B., Sacks F.M. Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials. Am J Cardiol. 69:1992;1286-1290.
8. The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) Trial. Phase I findings. N Engl J Med 1985;312:932-936.
9. Gibson C.M., Cannon C.P., Daley W.L.et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 93:1996;879-888.
10. Crea F., Davies G., Crake T.et al. Variability of coronary blood flow reserve assessed by Doppler catheter after successful thrombolysis in patients with acute myocardial infarction. Am Heart J. 125:1993;1547-1552.
11. Suryapranata H., Zijlstra F., MacLeod D.C., van den Brand M., de Feyter P.J., Serruys P.W. Predictive value of reactive hyperemic response on reperfusion on recovery of regional myocardial function after coronary angioplasty in acute myocardial infarction. Circulation. 89:1994;1109-1117.
12. Kern M.J., Moore J.A., Aguirre F.V.et al. Determination of angiographic (TIMI grade) blood flow by intracoronary doppler flow velocity during acute myocardial infarction. Circulation. 94:1996;1545-1552.
13. French J.K., Ellis C.J., Webber B.J.et al. Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected Thrombolysis in Myocardial Infarction (TIMI) frame count and stenosis severity. Am J Cardiol. 81:1998;665-671.
14. Uren N.G., Crake T., Lefroy D.C., de Silva R., Davies G.J., Maseri A. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med. 331:1994;222-227.
15. Meijer A., Verheugt F.W., Werter C.J., Lie K.I., van der Pol J.M., van Eenige M.J. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study: results of the APRICOT Study. Circulation. 87:1993;1524-1530.
16. White H.D., French J.K., Hamer A.W.et al. Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy. J Am Coll Cardiol. 25:1995;218-223.
17. Anderson J.L., Karagounis L.A., Becker L.C., Sorensen S.G., Menlove R.L. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study. Circulation. 87:1993;1829-1839.
18. Meijer A., Verheugt F.W., van Eenige M.J., Werter C.J. Left ventricular function at 3 months after successful thrombolysis: impact of reocclusion without reinfarction on ejection fraction, regional function, and remodeling. Circulation. 90:1994;1706-1714.
19. Vogt A., von Essen R., Tebbe U., Feuerer W., Appel K.F., Neuhaus K.L. Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies. J Am Coll Cardiol. 21:1993;1391-1395.
20. White H.D., Cross D.B., Elliott J.M., Norris R.M., Yee T.W. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation. 89:1994;61-67.
21. Gibson C.M., Cannon C.P., Piana R.N.et al. Angiographic predictors of reocclusion after thrombolysis: results from the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. J Am Coll Cardiol. 25:1995;582-589.
22. Claeys M.J., Vrints C.J., Bosmans J., Krug B., Blockx P.P., Snoeck J.P. Coronary flow reserve during coronary angioplasty in patients with a recent myocardial infarction: relation to stenosis and myocardial viability. J Am Coll Cardiol. 28:1996;1712-1719.
23. Kern M.J., Dupouy P., Drury J.H.et al. Role of coronary artery lumen enlargement in improving coronary blood flow after balloon angioplasty and stenting - a combined intravascular ultrasound doppler flow and imaging study. J Am Coll Cardiol. 29:1997;1520-1527.
24. Coumadin Aspirin Reinfarction Study (CARS) Investigators. Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Lancet 1997;350:389-396.
25. Meade T.W., Brennan P.J., Wilkes H.C., Zuhrie S.R. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. Lancet. 351:1998;233-241.